ADIL
NASDAQ · Pharmaceuticals
Adial Pharmaceuticals Inc
$2.48
-0.07 (-2.75%)
Open$2.53
Previous Close$2.55
Day High$2.60
Day Low$2.40
52W High$440.66
52W Low—
Volume—
Avg Volume197.8K
Market Cap5.57M
P/E Ratio—
EPS$-9.93
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+608.5% upside
Current
$2.48
$2.48
Target
$17.57
$17.57
$13.09
$17.57 avg
$22.70
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 13.49M | 12.56M | 11.54M |
| Net Income | 2.10M | 2.52M | 1.69M |
| Profit Margin | 15.6% | 20.1% | 14.6% |
| EBITDA | 3.80M | 3.63M | 3.04M |
| Free Cash Flow | 1.15M | 1.06M | 1.39M |
| Rev Growth | +2.7% | +18.2% | +12.4% |
| Debt/Equity | 0.15 | 0.14 | 0.18 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |